Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACON: LYR-220 in Chronic Rhinosinusitis
NCT05035654Phase 2Completed
- Sponsor
- Lyra Therapeutics, Inc.
- Start
- Nov 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 2 trial of LYR-201 in chronic rhinosinusitis (CRS), sponsored by Lyra Therapeutics, Inc.. Started Nov 2021; status: completed.
02
Drugs
LYR-201
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT05035654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035654.